Jason Tardio
Förmögenhet: 19 228 $ per 2026-06-30
Förmögenhet: 19 228 $ per 2026-06-30
Mr. Jason Tardio is a President & Chief Operating Officer at Immunic, Inc. Mr. Tardio was previously employed as a Chief Operating Officer by Ovid Therapeutics, Inc., a VP & Head-Multiple Sclerosis Franchise by Novartis, Inc., and a General Manager & Managing Director by Biogen, Inc. He received his undergraduate degree from The College of New Jersey and an MBA from St. Joseph's University.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
IMMUNIC, INC. 0,01 % | 2026-06-29 | 1 251 ( 0,01 % ) | 19 228 $ | 2026-06-30 |
| Företag | Position | Start |
|---|---|---|
| IMMUNIC, INC. | President | 2024-07-12 |
| Företag | Position | Slut |
|---|---|---|
| OVID THERAPEUTICS INC. | Verksamhetschef | 2024-07-11 |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Företagsledare/Principal | 2019-11-01 |
| BIOGEN INC. | Företagsledare/Principal | 2018-09-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 6 |
|---|---|
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a company based in San Francisco, CA. | Health Technology |
Ovid Therapeutics, Inc.
Ovid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Provides medicines to children and adults with neurological disorders | Health Technology |
The College of New Jersey
The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Joseph's University
St. Joseph's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Immunic, Inc.
Immunic, Inc. Pharmaceuticals: MajorHealth Technology Develops oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån